Emergent BioSolutions
EBS
#8517
Rank
โ‚ฌ0.23 B
Marketcap
4,64ย โ‚ฌ
Share price
-1.17%
Change (1 day)
-45.87%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2026 (TTM): -โ‚ฌ0.18 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are โ‚ฌ0.62 Billion. In 2025 the company made an earning of โ‚ฌ0.12 Billion, an increase over its 2024 earnings that were of -โ‚ฌ65.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.18 Billion-231.33%
2025 โ‚ฌ0.12 B-297.64%
2024 -โ‚ฌ65.53 Million-88.82%
2023 -โ‚ฌ0.59 Billion242.73%
2022 -โ‚ฌ0.18 Billion-153.8%
2021 โ‚ฌ0.31 B-20.43%
2020 โ‚ฌ0.39 B278.02%
2019 โ‚ฌ0.10 B27.11%
2018 โ‚ฌ83.17 M-27.12%
2017 โ‚ฌ0.11 B17.21%
2016 โ‚ฌ97.37 M0.45%
2015 โ‚ฌ96.93 M73.51%
2014 โ‚ฌ55.87 M41.36%
2013 โ‚ฌ39.52 M35.2%
2012 โ‚ฌ29.23 M0.4%
2011 โ‚ฌ29.11 M-56.46%
2010 โ‚ฌ66.87 M76.73%
2009 โ‚ฌ37.83 M32.94%
2008 โ‚ฌ28.46 M-5.62%
2007 โ‚ฌ30.16 M
2005 โ‚ฌ43.66 M269.89%
2004 โ‚ฌ11.8 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ6.35 B-3,680.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ6.12 B-3,554.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ6.52 B-3,776.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-โ‚ฌ10.67 Million-93.99%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
-โ‚ฌ10.16 Million-94.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚ฌ0.3 Billion 67.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.11 B-728.98%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel